// App-Quantinova.ai

1113 : Mir-194-3p suppresses tumorigenic potential of glioblastoma stem cells by targeting the canonical NF-kB pathway

Researchers

Presenter

  • Rajbir Singh

Principal Investigators

  • Kamalakannan Palanichamy

  • John R. Jacob

  • Arnab Chakravarti

Medical Centers

  • The Ohio State Univerisity, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Solid malignancies

  • Gliomas

Biomarkers

  • Interleukin 6

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved